OPHTHALMIC DROP Russian patent published in 2001 - IPC

FIELD: medicine, ophthalmology. SUBSTANCE: ophthalmic drops have high-molecular hyaluronic acid of 95% purity isolated from human umbilical cord as biologically active substance and physiological solution in the following ratio of components, wt.-%: hyaluronic acid, 0.05-0.2 and physiological solution, the balance. Invention can be used for treatment of traumatic damages, chemical burns and trophic damages of cornea, conjunctiva, for adaptation in contact lens using, in postoperative period after keratoplasty and keratotomy operations. Preparation is available for use under ambulatory conditions. EFFECT: improved functional results, decreased treatment time. 1 tbl, 3 ex